Host: |
Goat |
Applications: |
Pep-ELISA |
Reactivity: |
Human |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Goat polyclonal antibody anti-XCL1/XCL2 (Internal) is suitable for use in ELISA research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. NA |
Purification: |
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. |
Concentration: |
0.5 mg/mL |
Dilution Range: |
ELISA-antibody detection limit dilution 1:16000. |
Storage Instruction: |
Store at-20°C on receipt and minimise freeze-thaw cycles. |
Gene Symbol: |
XCL1 |
Gene ID: |
6375 |
Uniprot ID: |
XCL1_HUMAN |
Immunogen Region: |
Internal |
Accession Number: |
NP_002986.1; NP_003166.1 |
Specificity: |
XCL1 and CXL2 are almost identical and therefore this antibody is expected to recognize both proteins. |
Immunogen Sequence: |
RDVVRSMDRKSNTRN |
Function | Chemotactic activity for lymphocytes but not for monocytes or neutrophils. In thymus, mediates medullary accumulation of thymic dendritic cells and contributes to regulatoy T cell development, playing a role in self-tolerance establishment. |
Protein Name | LymphotactinAtacC Motif Chemokine 1Cytokine Scm-1LymphotaxinScm-1-AlphaSmall-Inducible Cytokine C1Xc Chemokine Ligand 1 |
Database Links | Reactome: R-HSA-380108Reactome: R-HSA-416476 |
Cellular Localisation | Secreted |
Alternative Antibody Names | Anti-Lymphotactin antibodyAnti-Atac antibodyAnti-C Motif Chemokine 1 antibodyAnti-Cytokine Scm-1 antibodyAnti-Lymphotaxin antibodyAnti-Scm-1-Alpha antibodyAnti-Small-Inducible Cytokine C1 antibodyAnti-Xc Chemokine Ligand 1 antibodyAnti-XCL1 antibodyAnti-LTN antibodyAnti-SCYC1 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance